A European survey on CAR-T cell analytical methods, conducted by the consortium T2Evolve, was recently published in Frontiers in Immunology.
- ART-TG
- Apr 24
- 1 min read
T2Evolve aims to accelerate the development of T cell-based gene therapies in Europe through collaborations between academic groups and pharmaceutical laboratories. T2Evolve is an IHI program involving 27 european partners from 9 countries, including ART-TG (Inserm).
Comments